#United States #Chicago #nRichDX #Revolution Sample Prep #AACR Annual Meeting

nRichDX to Exhibit Innovative Products at AACR Annual Meeting 2025

nRichDX, a prominent player in the liquid biopsy sample preparation field, will take center stage at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. Taking place from April 25 to April 30 at the McCormick Place Convention Center in Chicago, this notable event will spotlight groundbreaking developments in cancer research. The company is renowned for its Revolution Sample Prep System, designed to enhance sample preparation efficiency and accuracy in diagnosing various medical conditions.

At booth #4641, attendees can expect to see the unveiling of new products alongside critical new data presentations. Notably, nRichDX will co-present a poster with its collaborator, PacBio, on April 29, showcasing the latest advancements in their liquid biopsy technologies. The booths will open to the public on April 27 at noon and will remain open until noon on April 30, welcoming both industry veterans and newcomers to explore their innovation in liquid biopsy sample preparations.

The company is particularly excited about its latest offering, the Revolution Plus™ Sample Prep System. This state-of-the-art system comes complete with new nRicher Cartridges, which are engineered for maximum efficiency, enabling single extractions from a broader sample input volume range than any other commercially available kit on the market. These cartridges accommodate volumes from as low as 1 mL to as high as 100 mL, eliminating the need for pooling or transferring samples--a process known to reduce yield. This innovation stands out in the liquid biopsy sector, where obtaining high-yield analytes—such as circulating cell-free DNA (cfDNA) or circulating tumor cells (CTCs)—is imperative for effective diagnosis and treatment.

William Curtis, CEO of nRichDX, expressed his enthusiasm: "nRichDX is setting the standard for liquid biopsy sample preparation performance, workflow, and flexibility with solutions engineered to easily deliver the highest yields of rare analytes from an unequaled range of liquid biopsy sample types and sample volumes. We are proud to support and participate in this year's AACR Annual Meeting."

With an emphasis on quality, nRichDX has consistently outperformed its competitors, particularly when working with larger volume samples like blood, plasma, and urine. Moreover, the Revolution Sample Prep System addresses one of the most pressing challenges in precision medicine: the reliability of diagnostic results derived from liquid biopsy applications. Low yield of analytes can lead to incomplete or inaccurate diagnostics, a critical issue that nRichDX aims to mitigate with its innovative solutions.

Attendees interested in seeing firsthand how the Revolution Plus System works are encouraged to schedule a live demonstration in the nRichDX booth. The event is an excellent opportunity for researchers and clinicians to engage with nRichDX's experts, discuss the newest data, and explore how advancements in sample preparation technology can lead to improved performance in liquid biopsy assays.

To stay up-to-date with nRichDX’s schedule and the latest developments at the AACR Annual Meeting 2025, interested parties can visit nRichDX’s website for more information.

In conclusion, nRichDX continues to pave the way in liquid biopsy sample preparation—their commitment to innovation offers hope for more accurate diagnostic results in cancer treatment and beyond. By exhibiting groundbreaking technologies and data at the AACR Annual Meeting, nRichDX is poised to impact the future of cancer research significantly.